Joseph K. Schachle's most recent trade in Opus Genetics Inc. was a trade of 52,500 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Joseph K. Schachle | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 52,500 | 52,500 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Joseph K. Schachle | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 52,500 | 54,500 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Joseph K. Schachle | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 21 Mar 2024 | 2,000 | 2,000 | - | 2.1 | 4,100 | Common Stock |
| Opus Genetics Inc. | Joseph K. Schachle | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2023 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) |